Medicure Reports Highlights and Financial Results for FYE 2006
16th Aug 2006, 12:09 GMT
Medicure, a cardiovascular focused biopharmaceutical company, reported the results of operations for FYE 5/31/2006.
Medicure Reports Highlights and Financial Results for FYE 2006 related news:
- Medicure: Medicure Reports Highlights and Financial Results for FYE 2006 — Cardiology News from StratCenter.com
- Medicure Reports Highlights and Financial Results for Fiscal 2006 — ArriveNet : Press Releases
- Medicure Inc.: Medicure Reports Highlights and Financial Results for Fiscal 2006 — Market Wire - Medical and Healthcare
- CompuMed Announces Q3 FYE 2006 Financial Results — Partnerships/ Joint Ventures News from StratCenter.com
- Prospect Medical Holdings Reports FYE 2006 Q3 Results — Insurance/ Managed Care News from StratCenter.com
- China Medical Reports Unaudited Financial Results for Q1 of FYE 3/31/2007 — Ultrasound News from StratCenter.com
- Tutogen Medical Reports Q3 FYE 2006 Financial Results — Mammography News from StratCenter.com
- Pharmacyclics Announces Conference Call to Discuss 2006 FYE Results — Radiology News from StratCenter.com
- Opexa Reports Q2 Financial Results — Financial News News from StratCenter.com
- Perceptron Q4 and FYE Results for FYE 2006 — Operations-Related News from StratCenter.com
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress